On a mission to make healthcare more human — powered by pharmacogenomic and medication intelligence AI insights.

Our Focus

  • Empowering clinicians with tools and insights to deliver treatment plans tailored to each patient’s unique genetic profile, health history, and personal needs.

  • Advanced algorithms that combine pharmacogenomic data with AI-powered medication guidance to optimize prescribing, reduce adverse drug reactions, and improve outcomes.

  • Seamless, actionable intelligence embedded into clinical workflows, helping providers make informed decisions at the point of care without disrupting efficiency.

  • Engaging, evidence-based resources that equip healthcare teams with the skills to apply precision medicine in practice — and empower patients to take an active role in their health journey.

Meet the Team

  • Jeff McCormack, P.h.D - Founder

    Accomplished healthcare executive, entrepreneur, and scientist with a career spanning life sciences, biotechnology, and higher education leadership. Jeff has led clinical laboratories, co-founded multiple health tech ventures, and guided organizations through growth, innovation, and operational excellence. Passionate about connecting cutting-edge science to real-world healthcare impact.

  • Ryan Nowers, CEO

    Health tech innovator, strategist, and passionate about making healthcare more personal. With expertise in AI-driven clinical decision support and healthcare operations, he helps early-stage ventures scale, forge strategic partnerships, and bring transformative healthcare solutions to market.

  • Monique Bennett, P.h.D - COO

    Scientist and biotech problem-solver. With expertise in immunology, antibody discovery, and R&D operations, she guides early-stage ventures in building strong teams, optimizing scientific workflows, and charting clear paths from concept to impact.

  • Kavya Sharman, P.h.D - Head of Strategic Initiatives

    Kavya brings a rare blend of scientific expertise, strategic vision, and investment acumen to Emyra. As Managing Partner at Phase Capital and a Ph.D. data scientist with a background in neuroscience, computational biology, and data science, she has a proven track record of identifying and accelerating breakthrough health and biotech ventures.

Learn what’s next